Remove 2023 Remove Digital Health Remove healthcare technology Remove Telehealth
article thumbnail

CharmHealth Launches 2023 Innovation Challenge to Revolutionize Healthcare

Digital Health Global

Now Accepting Proposals for Disruptive Ideas That Address the Most Pressing Issues Across the Healthcare Landscape PLEASANTON, Calif.–(BUSINESS This year’s Innovation Challenge invites proposals designed to address the biggest issues faced by healthcare providers, patients and organizations. CEO of CharmHealth.

mHealth 88
article thumbnail

Healthcare Technology Innovators Partner with V2 Communications

Digital Health Global

This market has experienced unprecedented innovation and growth in recent years, propelled by emerging technologies that address operational and clinical issues that have long plagued the healthcare system. V2 creates integrated communications strategies that builds iconic healthcare technology companies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre

Digital Health Global

By leveraging the rapidly growing telehealth market, Cardio Diagnostics in partnership with Navierre is poised to revolutionize the patient cardiovascular care journey through earlier detection, accessible specialty care, and personalized prevention. . healthcare spending could be virtualized.

article thumbnail

Average multiples in HealthTech M&A during 2023

Lloyd Price

Exec Summary Overall, 2023 presented a mixed picture for HealthTech M&A. The average multiples in HealthTech M&A declined in 2023 compared to 2022. in 2023 (a decrease of 20%) EV/EBITDA: Down from 12.5x in 2023 (a decrease of 12%) Averages by sub-sector: Telehealth: 5.5x Healthcare IT: 3.5x

article thumbnail

Average multiples in HealthTech M&A : November 2023

Lloyd Price

Exec Summary The average multiples in HealthTech M&A deals in 2023 have declined compared to 2022, reflecting a more cautious approach by investors in the face of broader economic challenges. As of November 2023, the average enterprise value (EV) to sales multiple is 4.5x, down from 5.6x Healthcare IT companies: 3.5x

article thumbnail

Average Multiples and Key Drivers of Digital Musculoskeletal (MSK) M&A deals in 2023

Lloyd Price

Executive Summary: Digital MSK (musculoskeletal) companies have seen a decline in valuation multiples in 2023 compared to 2022. In 2022, the average enterprise value (EV) to sales multiple for digital MSK companies was 7.0x. However, as of November 2023, the average EV to sales multiple has declined to 5.5x.

article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

Executive Summary: The average multiples for digital therapeutics (DTx) M&A deals in 2023 are as follows: Enterprise value (EV) to sales: 5.6x Here are some additional insights into DTx M&A deals in 2023: The most active acquirers in the DTx M&A market are pharmaceutical companies, followed by technology companies.